Methyclothiazide
Diuretic drug
- C03AA08 (WHO)
- 6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- 135-07-9
Y
- 4121
- 7235
- DB00232
N
- 3978
N
- L3H46UAC61
- D00656
N
- ChEMBL1577
N
- DTXSID6023313
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Methyclothiazide is a thiazide diuretic.[1]
References
- ^ Wirfs MJ (2022). "Hypertension: Primary Essential". APRN and PAS complete guide to prescribing drug therapy 2022. [S.l.]: Springer. p. 366. ISBN 978-0-8261-8549-5.
- v
- t
- e
Symporter inhibitors
- Thiazides: Bendroflumethiazide
- Chlorothiazide
- Cyclopenthiazide
- Cyclothiazide
- Hydrochlorothiazide
- Hydroflumethiazide
- Methyclothiazide
- Polythiazide
- Trichlormethiazide; Others: Chlortalidone (chlorthalidone)
- Metolazone
See also: Receptor/signaling modulators
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e